List of Epi E Z Pen Jr drug patents

Epi E Z Pen Jr is owned by Mylan Speciality Lp.

Epi E Z Pen Jr contains Epinephrine.

Epi E Z Pen Jr has a total of 5 drug patents out of which 0 drug patents have expired.

Epi E Z Pen Jr was authorised for market use on 22 December, 1987.

Epi E Z Pen Jr is available in injectable;intramuscular, subcutaneous dosage forms.

The generics of Epi E Z Pen Jr are possible to be released after 11 September, 2025.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8870827 MYLAN SPECIALITY LP Automatic injector
Sep, 2025

(2 years from now)

US9586010 MYLAN SPECIALITY LP Automatic injector with needle cover
Sep, 2025

(2 years from now)

US7794432 MYLAN SPECIALITY LP Automatic injector with kickback attenuation
Sep, 2025

(2 years from now)

US7449012 MYLAN SPECIALITY LP Automatic injector
Sep, 2025

(2 years from now)

US8048035 MYLAN SPECIALITY LP Automatic injector with needle cover
Sep, 2025

(2 years from now)

Drugs and Companies using EPINEPHRINE ingredient

Market Authorisation Date: 22 December, 1987

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS

How can I launch a generic of EPI E Z PEN JR before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in